Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
LOADING
|||
| Metric | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | -0 | -0↓646.7% | -1↓649.1% |
| Operating Income | -10 | -36↓249.0% | -83↓129.6% |
| Net Income | -11 | -35↓226.6% | -78↓125.1% |
| EBITDA | -10 | -35↓234.9% | -77↓123.5% |
| EPS Diluted | -0.05 | -0.19↓258.5% | -0.38↓100.0% |